1
|
De Bernardo G, D’Urso G, Spadarella S, Giordano M, Leone G, Casapullo A. Analysis of the Fecal Metabolomic Profile in Breast vs. Different Formula Milk Feeding in Late Preterm Infants. Metabolites 2024; 14:72. [PMID: 38276307 PMCID: PMC10820811 DOI: 10.3390/metabo14010072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Revised: 01/12/2024] [Accepted: 01/19/2024] [Indexed: 01/27/2024] Open
Abstract
Human milk is the gold standard for infant nutrition, but when it is not available or insufficient to satisfy the needs of the infant, formula milk is proposed as an effective substitute. A prospective observational cohort study was conducted on late preterm infants fed with breast and two different formula milks. On this basis, they were divided into three groups: group FMPB (fed with formula + postbiotic), group FM (fed with standard formula), and group BM (breastfed). Stool samples for a metabolomic study were collected at T0 (5-7 days after birth), T1 (30 days of life), and T2 (90 days of life), giving rise to 74 samples analyzed via liquid chromatography coupled with high-resolution mass spectrometry. The T0, T1, and T2 LC-MS raw data were processed for Partial Least Square Discriminant Analysis (PLS-DA), followed by a statistical analysis. This preliminary study highlighted a good overlapping between the fecal metabolome of breast and substitute feeding systems, confirming the efficacy of the formula preparations as breast milk substitutes. Moreover, several similarities were also detected between the FMPB and BM metabolome, highlighting that the addition of a postbiotic to standard formula milk could be more effective and considered a better alternative to breast milk.
Collapse
Affiliation(s)
- Giuseppe De Bernardo
- Division of Pediatrics Neonatology and NICU, Ospedale Buon Consiglio Fatebenefratelli, 80123 Naples, Italy; (S.S.); (G.L.)
| | - Gilda D’Urso
- Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy;
| | - Simona Spadarella
- Division of Pediatrics Neonatology and NICU, Ospedale Buon Consiglio Fatebenefratelli, 80123 Naples, Italy; (S.S.); (G.L.)
| | - Maurizio Giordano
- Department of Clinical Medicine and Surgery, Federico II University, 80138 Naples, Italy;
| | - Giuseppina Leone
- Division of Pediatrics Neonatology and NICU, Ospedale Buon Consiglio Fatebenefratelli, 80123 Naples, Italy; (S.S.); (G.L.)
| | - Agostino Casapullo
- Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy;
| |
Collapse
|
2
|
Palma M, Spadarella S, Donnarumma B, Zollo G, Nunziata F, Cimbalo C, Castaldo A, Buonpensiero P, Terrone G, Varone A, Tosco A, Sepe A, Raia V. A complicated association between two different genetic rare disorders: cystic fibrosis and spinal muscular atrophy. Minerva Pediatr (Torino) 2022; 74:797-799. [PMID: 33820398 DOI: 10.23736/s2724-5276.19.05614-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Affiliation(s)
- Marta Palma
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy -
| | - Simona Spadarella
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Bernadette Donnarumma
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Giada Zollo
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Francesco Nunziata
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Chiara Cimbalo
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Alice Castaldo
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Paolo Buonpensiero
- Section of Pediatrics, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Gaetano Terrone
- Unit of Child Neuropsychiatry, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Antonio Varone
- Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy
| | - Antonella Tosco
- Regional Cystic Fibrosis Center, Pediatric Unit, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Angela Sepe
- Regional Cystic Fibrosis Center, Pediatric Unit, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| | - Valeria Raia
- Regional Cystic Fibrosis Center, Pediatric Unit, Department of Medical and Translational Sciences, University of Naples Federico II, Naples, Italy
| |
Collapse
|
3
|
Melis D, Rossi A, Pivonello R, Salerno M, Balivo F, Spadarella S, Muscogiuri G, Casa RD, Formisano P, Andria G, Colao A, Parenti G. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. Orphanet J Rare Dis 2015. [PMID: 26219379 PMCID: PMC4518509 DOI: 10.1186/s13023-015-0301-2] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In GSDIa, glucose 6-phosphate (G6P) accumulates in the endoplasmic reticulum (ER); in GSDIb, G6P levels are reduced in ER. G6P availability directly modulates the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1), an ER-bound enzyme playing a key role in the development of the metabolic syndrome (MS). OBJECTIVE To evaluate the prevalence of MS and Insulin Resistance (IR) in GSDIa and GSDIb patients. PATIENTS AND METHODS This was a prospective study. All the enrolled patients were followed at the Department of Pediatrics "Federico II" University of Naples for 10 years. Clinical and biochemical parameters of MS and the presence of IR were recorded. The results were correlated with the biochemical parameters of GSDI-related metabolic control. 10 GSDIa patient (median age 12.10 ± 1.50), 7 GSDIb patients (median age 14.90 ± 2.20 were enrolled in the study. They were compared to 20 and 14 age and sex matched controls, respectively. 10 GSDIa patients (median age 24.60 ± 1.50) and 6 GSDIb patients (median age 25.10 ± 2.00) completed the 10-year-follow-up. At the end of the study the patients' data were compared to 10 and 6 age and sex matched controls, respectively. RESULTS At study entry, 20 % GSDIa patients had MS and 80 % showed 2 criteria for MS. GSDIa patients showed higher HOMA-IR than controls and GSDIb patients (p < 0.001, p < 0.05), respectively. Baseline ISI was lower in GSDIa than controls (p < 0.001). QUICKI was significantly lower in GSDIa than in controls (p < 0.001). At the end of the study 70 % of GSDIa patients had MS and 30 % showed 2 criteria for MS. HOMA-IR was higher in GSDIa than controls (p < 0.01). Baseline ISI was higher in GSDIb than controls (p < 0.005) and GSD1a (p < 0.05). QUICKI was lower in GSD1a patients than in controls (p < 0.03). VAI was higher in GSDIa patients than controls (p < 0.001) and GSDIb patients (p = 0.002). CONCLUSIONS Our data showed high prevalence of IR and MS in GSDIa patients. We speculate a possible role of 11βHSD1 modulation by G6P availability. We suggest a routine metabolic assessment in GSDIa patients.
Collapse
Affiliation(s)
- Daniela Melis
- Department of Pediatrics, Azienda Ospedaliera Universitaria "Federico II", Via Sergio Pansini, 5 80131, Naples, Italy.
| | - Alessandro Rossi
- Department of Translational Medical Sciences, Section of Pediatrics, "Federico II" University, Naples, Italy.
| | - Rosario Pivonello
- Department of Medicine and Surgery, Section of Endocrinology, "Federico II" University, Naples, Italy.
| | - Mariacarolina Salerno
- Department of Translational Medical Sciences, Section of Pediatrics, "Federico II" University, Naples, Italy.
| | - Francesca Balivo
- Department of Translational Medical Sciences, Section of Pediatrics, "Federico II" University, Naples, Italy.
| | - Simona Spadarella
- Department of Translational Medical Sciences, Section of Pediatrics, "Federico II" University, Naples, Italy.
| | - Giovanna Muscogiuri
- Department of Medicine and Surgery, Section of Endocrinology, "Federico II" University, Naples, Italy.
| | - Roberto Della Casa
- Department of Translational Medical Sciences, Section of Pediatrics, "Federico II" University, Naples, Italy.
| | - Pietro Formisano
- Department of Translational Medical Sciences, Section of Clinical Pathology, "Federico II" University, Naples, Italy.
| | - Generoso Andria
- Department of Pediatrics, Azienda Ospedaliera Universitaria "Federico II", Via Sergio Pansini, 5 80131, Naples, Italy.
| | - Annamaria Colao
- Department of Medicine and Surgery, Section of Endocrinology, "Federico II" University, Naples, Italy.
| | - Giancarlo Parenti
- Department of Translational Medical Sciences, Section of Pediatrics, "Federico II" University, Naples, Italy.
| |
Collapse
|